Normal view MARC view ISBD view

Shared scheme for assessing drugs for multiple sclerosis: dealing with uncertainties about cost effectiveness of treatments is difficult problem.

Chadwick, David

Shared scheme for assessing drugs for multiple sclerosis: dealing with uncertainties about cost effectiveness of treatments is difficult problem. [electronic resource] - BMJ (Clinical research ed.) May 2003 - 1212-3 p. digital

Publication Type: Comment; Letter

ISSN: 1756-1833

Standard No.: 10.1136/bmj.326.7400.1212-a doi

Subjects--Topical Terms:
Azathioprine--economics
Cost-Benefit Analysis
Humans
Immunosuppressive Agents--economics
Multiple Sclerosis--drug therapy
Risk Sharing, Financial

Print
Cite
Add to your cart (remove)
Save record
BIBTEX Dublin Core MARCXML MARC (non-Unicode/MARC-8) MARC (Unicode/UTF-8) MARC (Unicode/UTF-8, Standard) MODS (XML) RIS ISBD
More searches

Search for this title in:
Other Libraries (WorldCat) Other Databases (Google Scholar) Online Stores (Bookfinder.com) Open Library (openlibrary.org)